Clinical Trial Update: Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal Function [Phase 1]

View source ↗

Summary

Phase 1 study evaluating elotuzumab in combination with lenalidomide and dexamethasone in multiple myeloma across different renal function levels; results were …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Elotuzumab (elotuzumab)
• Lenalidomide (lenalidomide)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Multiple Myeloma | Phase 1 | Status: COMPLETED | Results posted: 2016-01-27